AeroLeads people directory · profile
Robert Dempsey Email & Phone Number
Interim Chief Executive Officer
at
Ashvattha Therapeutics, Inc.
1 work email found
@asclepix.com
2 phones found area 978
LinkedIn matched
✓ Verified Jun 2026
4 data sources
Profile completeness 100%
Current company
Role
Interim Chief Executive Officer
Location
Greater Boston, United States, United States
Company size
Who is Robert Dempsey? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Robert Dempsey is listed as Interim Chief Executive Officer at Ashvattha Therapeutics, Inc., a company with 34 employees, based in Greater Boston, United States, United States. AeroLeads shows a work email signal at asclepix.com, phone signal with area code 978, and a matched LinkedIn profile for Robert Dempsey.
Robert Dempsey previously worked as Chief Executive Officer, President at Asclepix Therapeutics, Inc. and Chair of the Board of Directors at Tearsolutions Inc.. Robert Dempsey holds Master Of Business Administration - Mba, Business Administration And Management, General from Northeastern University.
Company email context
Email format at Ashvattha Therapeutics, Inc.
This section adds company-level context without repeating Robert Dempsey's masked contact details.
{first_initial}{last}@asclepix.com
86% confidence
AeroLeads found 1 current-domain work email signal for Robert Dempsey. Compare company email patterns before reaching out.
Profile bio
About Robert Dempsey
I was appointed to the position of CEO and President for AsclepiX Therapeutics to lead the transformation of ocular diseases and cancer through rapid clinical development. Our new chemical entities use pioneering computational biology methods to derive peptides that work naturally through existing, highly evolved, and self-regulating mechanisms of homeostasis. Prior, I served as the Chief Executive Officer for TearClear accelerating the business and commercial strategies which led to several value inflection points including a successful Series B financing and positive FDA engagements. I formerly served as the Group Vice President and Head of Global Ophthalmology at Shire, which was acquired by Takeda, and was responsible for one of the top 10 largest biopharma mergers of 2019, the divestiture of the Takeda lead ophthalmic drug, Xiidra® (lifitegrast ophthalmic solution) 5%, a transaction of up to $5.3 billion. This transaction for up to $5.3B from Shire’s initial investment of ~$165M in 2013 was recognized as one of the top 10 largest biopharma M&A deals in 2019.At Shire, I swiftly established a highly regarded reputation for Shire and dry eye disease in the Ophthalmology and Optometry markets. Leading the commercialization strategy that resulted in an industry leading launch, while overseeing the acquisition of four companies that contributed to the franchise pipeline of innovative candidates aimed at improving vision-related quality, was an accomplishment about which I am most proud.My professional affiliations and relationships in the eye care community are extensive and my recent philanthropic appointment serving on the Board Chair of the Holland Foundation for Sight Restoration where I focus my efforts outside of work to help expand corneal transplant surgery centers of excellence across the U.S.I serve as an Independent Director on the Boards for Humonix Biosciences, iVeena Inc., Neurotech and TearSolutions.
Listed skills include Ophthalmology, Pharmaceutical Industry, Medical Devices, Medical Affairs, and 25 others.
Current workplace
Robert Dempsey's current company
Company context helps verify the profile and gives searchers a useful next step.
Ashvattha Therapeutics, Inc.
15 roles
Robert Dempsey work experience
A career timeline built from the work history available for this profile.
Chief Executive Officer, President
Current
Mar 2021 - Present
Chair Of The Board Of Directors
Current
Dec 2023 - Present
Board Director
CurrentNeurotech Pharmaceuticals, Inc. is a biotechnology company developing transformational, sightsaving therapeutics for the treatment of chronic eye diseases. Its patented core technology platform, Encapsulated Cell Technology (ECT), is a genetically engineered implant that enables continuous delivery of protein drugs directly into the vitreous humor of the.
Jul 2022 - Present
Chair Of The Board Of Directors
Current
Oct 2019 - Present
Board Director
Current
Oct 2019 - Present
Chair Of The Board Of Directors, Co-Founder
Current
Jan 2018 - Present
Board Director
Aug 2018 - Dec 2021
Chief Executive Officer
Leading a global ophthalmic company pharmaceutical company with the goal of disrupting the way current topical medications are delivered to the ocular surface. Our lead product candidates in glaucoma will pave the way for future indications across multiple programs in development. This first in class platform of drugs enables medication delivery to.
Apr 2020 - Mar 2021
Group Vice President, Head Of Global Ophthalmics Franchise
Responsible for the Global build-out and launch of the Ophthalmic's Franchise. Primary focus will be to lead the international expansion and life cycle management of Lifitegrast, oversee the commercial development of pipeline programs for dry eye, infectious conjunctivitis and glaucoma and provide strategic direction of business development activities.
Jun 2017 - Dec 2019
Vice President, Eye Care
Will be responsible for developing and implementing the commercialization strategy for Dry Eye as well as identifying viable opportunities to bolster Shire’s business interests in eye care.
Feb 2014 - May 2017
Executive Director, Pharmaceutical Medical Science-North America
Seasoned pharmaceutical professional with 23 years of diverse leadership experience focused in Eye Care in the areas of medical and scientific affairs and commercial management. Effective management and organization of Medical Science Liaisons to maximize their efficiency and performance.Strategic relationships and development of key opinion leaders and.
Apr 2011 - Feb 2014
Vice President, Ophthalmology Medical Affairs
Aug 2010 - Aug 2011
Senior Director, Ophthalmic Medical Development
Sep 2007 - Aug 2010
Account Director, Managed Markets
May 2007 - Oct 2007
2 education records
Robert Dempsey education
Master Of Business Administration - Mba, Business Administration And Management, General
Northeastern University
Bachelor'S Degree, Healthcare Marketing
Northeastern University
FAQ
Frequently asked questions about Robert Dempsey
Quick answers generated from the profile data available on this page.
What company does Robert Dempsey work for?
Robert Dempsey works for Ashvattha Therapeutics, Inc..
What is Robert Dempsey's role at Ashvattha Therapeutics, Inc.?
Robert Dempsey is listed as Interim Chief Executive Officer at Ashvattha Therapeutics, Inc..
What is Robert Dempsey's email address?
AeroLeads has found 1 work email signal at @asclepix.com for Robert Dempsey at Ashvattha Therapeutics, Inc..
What is Robert Dempsey's phone number?
AeroLeads has found 2 phone signal(s) with area code 978 for Robert Dempsey at Ashvattha Therapeutics, Inc..
Where is Robert Dempsey based?
Robert Dempsey is based in Greater Boston, United States, United States while working with Ashvattha Therapeutics, Inc..
What companies has Robert Dempsey worked for?
Robert Dempsey has worked for Ashvattha Therapeutics, Inc., Asclepix Therapeutics, Inc., Tearsolutions Inc., Neurotech Pharmaceuticals, Inc., and Iveena.
Who are Robert Dempsey's colleagues at Ashvattha Therapeutics, Inc.?
Robert Dempsey's colleagues at Ashvattha Therapeutics, Inc. include Mehdi Paborji, Phd and James Tsai.
How can I contact Robert Dempsey?
You can use AeroLeads to view verified contact signals for Robert Dempsey at Ashvattha Therapeutics, Inc., including work email, phone, and LinkedIn data when available.
What schools did Robert Dempsey attend?
Robert Dempsey holds Master Of Business Administration - Mba, Business Administration And Management, General from Northeastern University.
What skills is Robert Dempsey known for?
Robert Dempsey is listed with skills including Ophthalmology, Pharmaceutical Industry, Medical Devices, Medical Affairs, Product Launch, Medicine, Leadership, and Clinical Trials.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial